ANTI-NEURODEGENERATIVE DISEASE AGENT

    公开(公告)号:US20220031690A1

    公开(公告)日:2022-02-03

    申请号:US17279760

    申请日:2019-09-24

    Abstract: The present invention addresses the problem of providing an orally-administrable anti-neurodegenerative disease agent having an action of accelerating neurocyte growth and an action of promoting neurite-outgrowth, and having excellent transfer properties to central nervous tissues. The problem is solved by providing an anti-neurodegenerative disease agent containing a compound represented by General formula 4 as an active ingredient, and having an action of accelerating neurocyte growth, an action of promoting neurite-outgrowth, and an action of scavenging reactive oxygen species. In General formula 4, R10 and R11 represent the same or different alkyl group having 2-8 carbon atoms, and the alkyl group may be either a straight chain or a branched chain. n represents an integer of 0 or 1, and X4− represents a suitable counter anion that is pharmaceutically acceptable.

Patent Agency Ranking